Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COCP · as of Jun 8, 2026
Key Statistics
Explore Cocrystal Pharma, Inc. Data
cocp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cocp competitorsCOCP
BOLT
BRTX
CING
DWTX
EVGNStock Performance
Full HistoryAbout Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based te…
what is cocrystal pharma, inc. · cocp stock overview · cocrystal pharma, inc. company profile · who is cocrystal pharma, inc. ceo · cocp NASDAQ · cocrystal pharma, inc. headquarters · cocrystal pharma, inc. business segments
About Stock Overview & Key Data
Cocrystal Pharma, Inc. (COCP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 22, 2012. As of the latest trading session, COCP stock price is $1.01, with a market capitalization of $10.4M. The stock has returned -38.79% over the past 12 months and +3.17% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cocrystal Pharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cocrystal Pharma, Inc. reported revenue of — and net income of -$8.8M. For detailed data — including Cocrystal Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cocrystal Pharma, Inc. (COCP) stock price is $1.01. The stock is traded on NASDAQ under the ticker symbol COCP. The 52-week range is $0.86 – $2.67.